ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ocular Therapeutics Sustained Release TKI Trial"
Episode Synopsis
We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.
More episodes of the podcast Retina Synthesis
Stem Cell Therapy for Geographic Atrophy
19/11/2025
8 mg Aflibercept in Diabetic Macular Edema
08/10/2025
Subretinal Gene Therapy for Neovascular AMD
03/10/2025
In God we trust